Effects of endogenous and exogenous nitric oxide on endothelin-1 production in cultured vascular endothelial cells

European Journal of Pharmacology

Volumn 364, Issue 1, 1999, Pages 65-73

  Mitsutomi, Naoko ^a   Akashi, Chitose ^a   Odagiri, Junko ^a   Matsumura, Yasuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

cGMP; Endothelial cell; Endothelin 1; Nitric oxide (NO); Nitric oxide (NO) donor

Indexed keywords

1,2,4 OXADIAZOLE DERIVATIVE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLE 1 OXYL 3 OXIDE; 4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; CYCLIC GMP; ENDOTHELIN 1; GUANYLATE CYCLASE; LINSIDOMINE; MESSENGER RNA; N ACETYL S NITROSOPENICILLAMINE; N(G) METHYLARGININE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; IN VITRO STUDY; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SWINE;

ANIMALS; AORTA; BENZOATES; CELLS, CULTURED; CYCLIC GMP; ENDOTHELIN-1; ENDOTHELINS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; IMIDAZOLES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRO COMPOUNDS; OXADIAZOLES; PROTEIN PRECURSORS; QUINOXALINES; RNA, MESSENGER; SWINE;

EID: 0032907028     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00806-1     Document Type: Article

References (34)

1. ·NO through a radical reaction. Biochemistry. 32:1993;827-832.
2. Banting J.D., Fiberg P., Adams M.A. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction. J. Hypertens. 14:1996;975-981.
3. Boulanger C., Lüscher T.F. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85:1991;587-590.
4. Brunner F., Stessel H., Kukovetz W.R. Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion. FEBS Lett. 376:1995;262-266.
5. Décout J.-L., Roy B., Fontecave M., Muller J.-C., Williams P.H., Loyaux D. Decomposition of FK409, a new vasodilator: identification of nitric oxide as a metabolite. Bioorg. Med. Chem. Lett. 5:1995;973-978.
6. Elizabeth A.K., Fung H.-L. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J. Pharmacol. Exp. Ther. 255:1990;1256-1264.
7. Estrada C., Gomez C., Martin C., Moncada S., Gonzalez C. Nitric oxide mediates tumor necrosis factor-a cytotoxicity in endothelial cells. Biochem. Biophys. Res. Commun. 186:1992;475-482.
8. Feelisch M., Noack E.A. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur. J. Pharmacol. 139:1987;19-30.
9. Förstermann U., Schumidt H.H.H.W., Pollock J.S., Sheng H., Mitchell J.A., Warner T.D., Nakane M., Murad F. Isoforms of nitric oxide synthase: characterization and purification from different cell types. Biochem. Pharmacol. 42:1991;1849-1857.
10. Fukuyama S., Kita Y., Hirasawa Y., Azuma T., Sato A., Morokoshi N., Koda S., Yasuda T., Oka S., Sakurai H. A new nitric oxide (NO) releaser: spontaneous NO release from FK409. Free Radic. Res. 23:1995;443-452.
11. Garthwaite J., Southan E., Boulton C.L., Nielsen E.B., Suhmidt K., Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48:1995;184-188.
12. Hexum T.D., Hoeger C., River J.E., Baird A., Brown M.R. Characterization of endothelin secretion by vascular endothelial cells. Biochem. Biophys. Res. Commun. 167:1990;294-300.
13. Hilkert R.J., Lee M.-E., Quertermous T. Genetic regration of endothelin-1 in vascular endothelial cells. Trends Cardiovasc. Med. 2:1992;129-133.
14. Hinson J.P., Kapas S., Cameron L.A. Differential effects of endogenous and exogenous nitric oxide on the release of endothelin-1 from the intact perfused rat adrenal gland in situ. FEBS Lett. 379:1996;7-10.
15. Hrabie J.A., Klose J.R., Wink D.A., Keefer L.K. New nitric oxide-releasing zwitterions derived from polyamines. J. Org. Chem. 58:1993;1472-1476.
16. Ikegawa R., Matsumura Y., Tsukahara Y., Takaoka M., Morimoto S. Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme. Biochem. Biophys. Res. Commun. 171:1990;669-675.
17. Imai T., Hirata Y., Emori T., Yanagisawa M., Masaki T., Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension. 19:1992;753-757.
18. Kato M., Nishino S., Ohno M., Fukuyama S., Kita Y., Hirasawa Y., Nakanishi I., Takasugi H., Sakane K. New reagents for controlled release of nitric oxide. Structure-stability relationships. Bioorg. Med. Chem. Lett. 6:1996;33-38.
19. Keefer, L.K., 'NONOates' (1-substituted diazen-1-ium-1,2-diolates) as NO donors: convenient nitric oxide dosage forms. Methods Enzymol. in press.
20. Kita Y., Hirasawa Y., Maeda K., Nishino M., Yoshida K. Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409. Eur. J. Pharmacol. 257:1994;123-130.
21. Kita Y., Fukuyama S., Hirasawa Y. Close correlation between nitric oxide (NO) formation from NO releasers and the biological activities of these agents in rats. Jpn. J. Pharmacol. 69:1995;69-74.
22. Kourembanas S., McQuillan L.P., Leung G.K., Faller D.V. Nitric oxide regrates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin. Invest. 92:1993;99-104.
23. Kuchan M.J., Frangos J.A. Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am. J. Physiol. 264:1993;H150-H156.
24. Matsumura Y., Ikegawa R., Takaoka M., Morimoto S. Conversion of porcine big endothelin to endothelin by an extract from the porcine aortic endothelial cells. Biochem. Biophys. Res. Commun. 167:1990;203-210.
25. Matsumura Y., Ikegawa R., Tsukahara Y., Takaoka M., Morimoto S. Conversion of big endothelin-1 to endothelin-1 by two types of metalloproteinases derived from porcine aortic endothelial cells. FEBS Lett. 272:1990;166-170.
26. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
27. Murata S., Matsumura Y., Takada K., Asai Y., Takaoka M., Morimoto S. Role of transforming growth factor-b1 on platelet-induced enhancement of endothelin-1 production in cultured vascular endothelial cells. J. Pharmacol. Exp. Ther. 274:1995;1524-1530.
28. Opgenorth T.J., Wu-Wong J.R., Shiosaki K. Endothelin converting enzymes. FASEB J. 6:1992;2653-2659.
29. Richard V., Hogie M., Clozel M., Löffer B.-M., Thuillez C. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation. 91:1995;771-775.
30. Thompson A., Vareri C.R., Lieberthal W. Endothelin receptor A blockade alters hemodynamic response to nitric oxide inhibition in rats. Am. J. Physiol. 269:1995;H743-H748.
31. B receptor in endothelial cells. J. Biol. Chem. 269:1994;21778-21785.
32. Wink D.A., Cook J.A., Christodoulou D., Krishna M.C., Pacelli R., Kim S., DeGraff W., Gamson J., Vodovotz Y., Russo A., Mitchell J.B. Nitric oxide and some nitric oxide compounds enhance the cytotoxicity of cisplatin. Nitric Oxide. 1:1997;88-94.
33. Xia Y., Dawson V.L., Dawson T.M., Synder S.H., Zweier J.L. Nitric oxide syntase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6770-6774.
34. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.